Diabetes Sector Targeted By Leading Players

It is BMI's view that the diabetes epidemic in India represents a significant opportunity for drugmakers. The debilitating condition accounts for a large portion of the country's burden of disease and the problem is growing. Appreciating this situation, two of leading multinational drugmakers have announced plans for launching their innovative products onto the

To read the full article, please choose one of the following options: